Business News • PR NewsWire • Citadel and Citadel Securities Accelerate COVID-19 Research and Vaccine Development Initiatives at Leading UK Medical Institutions

Citadel and Citadel Securities Accelerate COVID-19 Research and Vaccine Development Initiatives at Leading UK Medical Institutions

Citadel and Citadel Securities Accelerate COVID-19 Research and Vaccine Development Initiatives at Leading UK Medical Institutions

LONDON, May 1, 2020 /PRNewswire/ -- The Partners of Citadel and Citadel Securities today announced £3 million of support to advance scientific initiatives at two of London's leading medical institutions. The work will focus on immunology research to accelerate COVID-19 treatment and...

View More : https://www.prnewswire.com:443/news-releases/citadel-and-citadel-securities-accelerate-covid-19-research-and-vaccine-dev...

Releted News by prnewswire

Lincoln International Enhances Global Financial Sponsors Coverage with Hire of Florus Plantenga as Managing Director

Intertek Launches Protek - The World's First Health, Safety and Wellbeing Assurance Programme for People, Workplaces and Public Spaces

VEON Announces Annual General Meeting; Ursula Burns to Step Down as Chairman

Citadel and Citadel Securities Accelerate COVID-19 Research and Vaccine Development Initiatives at Leading UK Medical Institutions

Delek Group - Conference Call for Investors Following Publication of Financial Statements

Castellum Begins Construction on Malmö's new Swedish National Courts Building - Invests 1.3 Billion Kronor

LeoVegas Launches LiveCasino.com